StockData
BioCorRx Inc. logo

BioCorRx Inc. (BICX) stock

BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.25+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.30MP/E –Yield –

BioCorRx profit margin

Profit margin (net margin) is net income as a percentage of revenue.

BioCorRx's profit margin for the twelve months ending Sep 30, 2025 was -543.8%. For fiscal 2025 it was -431.5%, against -66616.1% the year before. The highest annual figure on record is -53.0% in fiscal 2011.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-431.5%+66184.6
FY2024Dec 31, 2024-66616.1%−62387.2
FY2023Dec 31, 2023-4228.9%−2182.1
FY2022Dec 31, 2022-2046.8%+8747.6
FY2021Dec 31, 2021-10794.3%−7934.7
FY2020Dec 31, 2020-2859.6%−342.2
FY2019Dec 31, 2019-2517.4%−769.3
FY2018Dec 31, 2018-1748.1%+2771.4
FY2017Dec 31, 2017-4519.5%−3678.3
FY2016Dec 31, 2016-841.3%−336.7
FY2015Dec 31, 2015-504.6%−237.5
FY2014Dec 31, 2014-267.1%+269.8
FY2013Dec 31, 2013-536.9%−434.9
FY2012Dec 31, 2012-102.0%−49.0
FY2011Dec 31, 2011-53.0%+54.1
FY2010Dec 31, 2010-107.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-1096.7%−473.0
Q1 FY2026Mar 31, 2026-387.4%+29707.6
Q3 FY2025Sep 30, 2025-301.9%+33863.2
Q2 FY2025Jun 30, 2025-692.0%+4424.7
Q1 FY2025Mar 31, 2025-623.7%+7925.8
Q2 FY2024Jun 30, 2024-30095.1%−25391.5
Q1 FY2024Mar 31, 2024-34165.1%−31666.2
Q4 FY2023Dec 31, 2023-5116.7%−511.1
Q3 FY2023Sep 30, 2023-8549.5%+1334.9
Q2 FY2023Jun 30, 2023-4703.6%+10943.0
Q1 FY2023Mar 31, 2023-2498.9%+1572.2
Q1 FY2022Mar 31, 2022-4605.7%−1971.7
Q2 FY2021Sep 30, 2021-9884.4%−7692.8
Q1 FY2021Mar 31, 2021-15646.6%−12724.3
Q4 FY2020Dec 31, 2020-4071.0%−2144.6
Q3 FY2020Sep 30, 2020-2634.0%−413.6
Q2 FY2020Jun 30, 2020-2191.7%+901.8
Q1 FY2020Mar 31, 2020-2922.3%−209.9
Q4 FY2019Dec 31, 2019-1926.5%+2862.2
Q3 FY2019Sep 30, 2019-2220.4%+180.3
Q2 FY2019Jun 30, 2019-3093.5%−1855.5
Q1 FY2019Mar 31, 2019-2712.4%−2034.3
Q4 FY2018Dec 31, 2018-4788.7%−3835.5
Q3 FY2018Sep 30, 2018-2400.6%−1653.9
Q2 FY2018Jun 30, 2018-1238.0%−6606.9
Q1 FY2018Mar 31, 2018-678.1%+27882.1
Q4 FY2017Dec 31, 2017-953.3%+508.0
Q3 FY2017Sep 30, 2017-746.7%+809.9
Q2 FY2017Jun 30, 20175368.9%+5940.3
Q1 FY2017Mar 31, 2017-28560.2%−28330.8
Q4 FY2016Dec 31, 2016-1461.2%−1468.6
Q3 FY2016Sep 30, 2016-1556.6%–
Q2 FY2016Jun 30, 2016-571.4%–
Q1 FY2016Mar 31, 2016-229.4%–
Q4 FY2015Dec 31, 20157.3%–

More BioCorRx figures

See a number that looks wrong?